Immune checkpoint molecules on ILC2s as potential therapeutic targets for allergic diseases. Morita H, Saito H, Matsumoto K. J Allergy Clin Immunol 2021 Oct 27. pii: S0091-6749(21)01633.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Morita H, Saito H, Matsumoto K. Immune checkpoint molecules on ILC2s as potential therapeutic targets for allergic diseases. J Allergy Clin Immunol 2021 Oct 27. pii: S0091-6749(21)01633.
PMID: 34718042